Matt Kapusta, uniQure's chief executive, said the company remains committed to engaging with the FDA to see if there is a way forward for gene therapy AMT-130. uniQure looks like it may have to run ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results